A Retrospective Trail Investigating Temozolomide Neoadjuvant Chemotherapy Combined with Radiotherapy in Low-Grade Pituitary Tumors

Table 3

Comparison of serum levels (±s).

Groups		PRL (μg/L)		IGF-1 (ng/L)		GH (μg/L)
		Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Combined group	37
Control group	30
		0.053	7.949	0.352	3.067	0.28	19.916
		0.958	<0.001	0.726	0.003	0.78	<0.001